|
Lipkin, Steven M |
Weill Medical Coll Of Cornell Univ |
(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance |
|
RFA-CA-17-017: Research Answers to NCI's Provocative Questions |
|
Vilar-Sanchez, Eduardo |
University Of Tx Md Anderson Can Ctr |
Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome |
|
RFA-CA-15-008: Research Answers to NCI's Provocative Questions |
|
Malafa, Mokenge P |
H. Lee Moffitt Cancer Ctr & Res Inst |
Novel Therapy to Inhibit IPMN Progression |
|
PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program |
|
Katona, Bryson William |
University Of Pennsylvania |
Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants |
|
PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
|
El-Serag, Hashem B |
Baylor College Of Medicine |
Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome |
|
PAR-20-077: National Cancer Institute Program Project Applications |
|
Chan, Andrew T |
Massachusetts General Hospital |
Precision Prevention Research Program |
|
PAR-19-349: NCI Outstanding Investigator Award |
|
Chang, Su-Hsin |
Washington University |
Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective |
|
PAR-19-279: Provocative Questions (PQs) in Multiple Myeloma Disparities Research |
|
Schmit, Stephanie L |
Cleveland Clinic Lerner Com-Cwru |
Variation in tumor-associated immune profiles and colorectal cancer outcomes |
|
PAR-18-654: Basic Research in Cancer Health Disparities |
|
Chan, Andrew T |
Massachusetts General Hospital |
Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Allen, Peter J |
Duke University |
Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Vilar-Sanchez, Eduardo |
University Of Tx Md Anderson Can Ctr |
Cancer Immune-Interception for Lynch Syndrome |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Chung, Raymond T |
Massachusetts General Hospital |
Trial of Statins for Chemoprevention in Hepatocellular Carcinoma |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Markowitz, Sanford D. |
Case Western Reserve University |
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment |
|
PAR-15-342: NCI Outstanding Investigator Award |
|
Wang, Thomas D |
University Of Michigan At Ann Arbor |
Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma |
Barrett's Esophagus Translational Research Network |
PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
|
Chak, Amitabh |
Case Western Reserve University |
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma |
Barrett's Esophagus Translational Research Network |
PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
